{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:18:41Z","timestamp":1768882721575,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.4065\/mcp.2010.0841","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T02:57:10Z","timestamp":1305601030000},"page":"531-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm?"],"prefix":"10.4065","volume":"86","author":[{"given":"Gerard O.","family":"Oghlakian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilke","family":"Sipahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.4065\/mcp.2010.0841_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/mcp.2010.0841_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.4065\/mcp.2010.0841_bib3","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/hc1102.105289","article-title":"New concepts in diastolic dysfunction and diastolic heart failure; Part I: diagnosis, prognosis, and measurements of diastolic function","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/mcp.2010.0841_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (AD-HERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.4065\/mcp.2010.0841_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","article-title":"Epidemiology and clinical course of heart failure with preserved ejection fraction","volume":"13","author":"Lam","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"suppl","key":"10.4065\/mcp.2010.0841_bib6","first-page":"III48","article-title":"Heart failure with normal ejection fraction: the V-HeFT Study","volume":"81(2)","author":"Cohn","year":"1990","journal-title":"Circulation"},{"issue":"3","key":"10.4065\/mcp.2010.0841_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.4065\/mcp.2010.0841_bib8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur Heart J"},{"issue":"2","key":"10.4065\/mcp.2010.0841_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2008.09.031","article-title":"Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry","volume":"53","author":"Hernandez","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.4065\/mcp.2010.0841_bib10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.109.909614","article-title":"Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial","volume":"121","author":"Zile","year":"2010","journal-title":"Circulation"},{"issue":"20","key":"10.4065\/mcp.2010.0841_bib11","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure? A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction (HFNEF) by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"issue":"21","key":"10.4065\/mcp.2010.0841_bib12","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/CIRCULATIONAHA.108.787101","article-title":"Exercise-induced pulmonary arterial hypertension","volume":"118","author":"Tolle","year":"2008","journal-title":"Circulation"},{"issue":"9386","key":"10.4065\/mcp.2010.0841_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"23","key":"10.4065\/mcp.2010.0841_bib14","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"issue":"19","key":"10.4065\/mcp.2010.0841_bib15","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"issue":"3","key":"10.4065\/mcp.2010.0841_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cardfail.2005.01.005","article-title":"Is heart failure with decent systole due to bad diastole?","volume":"11","author":"Kass","year":"2005","journal-title":"J Card Fail"},{"issue":"1","key":"10.4065\/mcp.2010.0841_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0025-7125(03)00125-1","article-title":"Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system","volume":"88","author":"Gonz\u00e1lez","year":"2004","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.4065\/mcp.2010.0841_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.hco.0000168533.76966.49","article-title":"Early recognition and treatment of hypertensive heart disease","volume":"20","author":"Mitchell","year":"2005","journal-title":"Curr Opin Cardiol"},{"issue":"12","key":"10.4065\/mcp.2010.0841_bib19","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"issue":"19","key":"10.4065\/mcp.2010.0841_bib20","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure: abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"10.4065\/mcp.2010.0841_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cardfail.2009.03.006","article-title":"Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction","volume":"15","author":"Desai","year":"2009","journal-title":"J Card Fail"},{"issue":"5","key":"10.4065\/mcp.2010.0841_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.CIR.0000048123.22359.A0","article-title":"Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations","volume":"107","author":"Kawaguchi","year":"2003","journal-title":"Circulation"},{"issue":"20","key":"10.4065\/mcp.2010.0841_bib23","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"issue":"13","key":"10.4065\/mcp.2010.0841_bib24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study","volume":"53","author":"Lam","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.4065\/mcp.2010.0841_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat Med"},{"issue":"17","key":"10.4065\/mcp.2010.0841_bib26","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"issue":"14","key":"10.4065\/mcp.2010.0841_bib27","first-page":"e391","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"10.4065\/mcp.2010.0841_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0841_bib29","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0841_bib30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"issue":"17","key":"10.4065\/mcp.2010.0841_bib31","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/01.CIR.0000146819.43235.A9","volume":"110","author":"Young","year":"2004","journal-title":"Circulation"},{"key":"10.4065\/mcp.2010.0841_bib32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0841_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction: Eplerenone Post-AMI Heart Failure Efficacy and Survival Study","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"issue":"22","key":"10.4065\/mcp.2010.0841_bib34","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/CIRCULATIONAHA.107.762229","article-title":"Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"118","author":"Davis","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.4065\/mcp.2010.0841_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/hrt.2007.117978","article-title":"The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction","volume":"94","author":"Yip","year":"2008","journal-title":"Heart"},{"issue":"4","key":"10.4065\/mcp.2010.0841_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/CIRCHEARTFAILURE.109.898916","article-title":"A randomized, double-blinded trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility","volume":"3","author":"Kitzman","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"9579","key":"10.4065\/mcp.2010.0841_bib37","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(07)60980-5","article-title":"Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial","volume":"369","author":"Solomon","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.4065\/mcp.2010.0841_bib38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","article-title":"Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure","volume":"110","author":"Mottram","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.4065\/mcp.2010.0841_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"issue":"6","key":"10.4065\/mcp.2010.0841_bib41","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2009.06.067","article-title":"Treatment of heart failure with normal ejection fraction: an inconvenient truth","volume":"55","author":"Paulus","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.4065\/mcp.2010.0841_bib42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cardfail.2009.11.007","article-title":"The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis","volume":"16","author":"Shah","year":"2010","journal-title":"J Card Fail"},{"issue":"19","key":"10.4065\/mcp.2010.0841_bib43","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.4065\/mcp.2010.0841_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejheart.2004.02.003","article-title":"Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function: results of the Swedish Doppler-echocardiographic study (SWEDIC)","volume":"6","author":"Bergstr\u00f6m","year":"2004","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.4065\/mcp.2010.0841_bib45","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.amjcard.2004.05.004","article-title":"Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction","volume":"94","author":"Takeda","year":"2004","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.4065\/mcp.2010.0841_bib46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1388-9842(03)00054-0","article-title":"Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension: a prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol","volume":"5","author":"Nodari","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.4065\/mcp.2010.0841_bib47","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.amjcard.2006.12.056","article-title":"Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice","volume":"99","author":"Massie","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.4065\/mcp.2010.0841_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/eurjhf\/hfp193","article-title":"Rationale and design of the \u03b2-blocker in heart failure with normal left ventricular ejection fraction (\u03b2-PRESERVE) study","volume":"12","author":"Zhou","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.4065\/mcp.2010.0841_bib49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cardfail.2005.04.003","article-title":"Rationale and design of a randomized trial to assess the effects of \u03b2-blocker in diastolic heart failure: Japanese Diastolic Heart Failure Study (J-DHF)","volume":"11","author":"Hori","year":"2005","journal-title":"J Card Fail"},{"issue":"12","key":"10.4065\/mcp.2010.0841_bib50","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0002-9149(90)90937-V","article-title":"Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance","volume":"66","author":"Setaro","year":"1990","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.4065\/mcp.2010.0841_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1742-1241.2002.tb11193.x","article-title":"Effect of verapamil in elderly patients with left ventricular diastolic dysfunction as a cause of congestive heart failure","volume":"56","author":"Hung","year":"2002","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.4065\/mcp.2010.0841_bib52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"issue":"22","key":"10.4065\/mcp.2010.0841_bib53","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"issue":"9645","key":"10.4065\/mcp.2010.0841_bib54","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Gissi-HF Investigators","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.4065\/mcp.2010.0841_bib55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.104.519876","article-title":"Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report","volume":"112","author":"Fukuta","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.4065\/mcp.2010.0841_bib56","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/jama.2008.1022","article-title":"Left ventricular function and exercise capacity","volume":"301","author":"Grewal","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.4065\/mcp.2010.0841_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0002-8703(92)90932-L","article-title":"Abnormalities of diastolic filling of the left ventricle associated with aging are less pronounced in exercise-trained individuals","volume":"124","author":"Takemoto","year":"1992","journal-title":"Am Heart J"},{"issue":"11","key":"10.4065\/mcp.2010.0841_bib58","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1249\/mss.0b013e318145b642","article-title":"Normalization of diastolic dysfunction in type 2 diabetics after exercise training","volume":"39","author":"Brassard","year":"2007","journal-title":"Med Sci Sports Exerc"},{"issue":"4","key":"10.4065\/mcp.2010.0841_bib59","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.hrtlng.2004.01.004","article-title":"Home-based exercise improves functional performance and quality of life in women with diastolic heart failure","volume":"33","author":"Gary","year":"2004","journal-title":"Heart Lung"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611600505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611600505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T23:06:55Z","timestamp":1710457615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611600505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0025619611600505"],"URL":"https:\/\/doi.org\/10.4065\/mcp.2010.0841","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm?","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/mcp.2010.0841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}